Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delpharm
Boulogne-Billancourt, France
- Ownership
- Private
- Employees
- ~6500
- Development stage
- Commercial
01
Overview
Delpharm operates as a leading global CDMO, providing end-to-end pharmaceutical development and manufacturing services. It produces over one billion units annually in most dosage forms—including solid, semi-solid, liquid, sterile injectables, prefilled syringes—and supports clinical to commercial scale. The company serves more than 170 customers worldwide with a focus on quality and regulatory compliance. No proprietary clinical results as it does not develop its own drugs.
- Modalities
- Small moleculeBiologicMedical device (manufacturing)HormoneCytotoxic productsRecombinant proteinPeptidesVaccine
- Industry
- Contract Manufacturing Organization
02
Partnerships
Partnerships with major pharmaceutical companies through site acquisitions from Astellas (Meppel), Novartis/Sandoz (Boucherville), GSK (Poznań), Roche Segrate plant in Milano.
Beyond the preview
Go deeper on Delpharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Delpharm.